German Stocks: Continental champs
16 No. of Symbols
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−3.25 CHF
−2.40 B CHF
43.82 B CHF
982.35 M
About Bayer AG
Sector
Industry
CEO
William N. Anderson
Website
Headquarters
Leverkusen
Founded
1952
ISIN
DE000BAY0017
FIGI
BBG000BBWT49
Bayer AG engages in the business of life science fields of healthcare and nutrition. It operates through the following segments: Crop Science, Pharmaceuticals, and Consumer Health. The Crop Science segment includes developing, producing, and marketing products in seeds and plant traits, crop protection, digital solutions, and customer services to promote sustainable agriculture. The Pharmaceuticals segment is involved in prescription products especially for cardiology and women’s health; specialty therapeutics in the areas of oncology, hematology, ophthalmology, and cell and gene therapy; diagnostic imaging equipment; and necessary contrast agents. The Consumer Health segment focuses on non-prescription products in the dermatology, nutritional supplements, digestive health, allergy, cough and cold, and pain and cardiovascular risk prevention categories. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
BAYZ3875861
Monsanto Company 3.6% 15-JUL-2042Yield to maturity
—
Maturity date
Jul 15, 2042
BAYZ4646646
Bayer US Finance II LLC 4.625% 25-JUN-2038Yield to maturity
—
Maturity date
Jun 25, 2038
BAYZ4810288
Bayer Corporation 6.65% 15-FEB-2028Yield to maturity
—
Maturity date
Feb 15, 2028
BAYZ5530169
Bayer US Finance II LLC 4.65% 15-NOV-2043Yield to maturity
—
Maturity date
Nov 15, 2043
BAYZ3673141
Monsanto Company 5.875% 15-APR-2038Yield to maturity
—
Maturity date
Apr 15, 2038
BAYZ5705352
Bayer US Finance LLC 6.375% 21-NOV-2030Yield to maturity
—
Maturity date
Nov 21, 2030
BAYZ4140707
Monsanto Company 4.4% 15-JUL-2044Yield to maturity
—
Maturity date
Jul 15, 2044
BAYZ5705350
Bayer US Finance LLC 6.25% 21-JAN-2029Yield to maturity
—
Maturity date
Jan 21, 2029
BAYZ4067527
Monsanto Company 4.65% 15-NOV-2043Yield to maturity
—
Maturity date
Nov 15, 2043
BAYZ3949796
Conceptus, Inc. 5.0% 15-DEC-2031Yield to maturity
—
Maturity date
Dec 15, 2031
BAYZ4790623
Bayer US Finance II LLC 5.875% 15-APR-2038Yield to maturity
—
Maturity date
Apr 15, 2038
See all BAYN bonds
Curated watchlists where BAYN is featured.
Frequently Asked Questions
The current price of BAYN is 67.99 CHF — it hasn't changed in the past 24 hours. Watch Bayer AG stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange Bayer AG stocks are traded under the ticker BAYN.
We've gathered analysts' opinions on Bayer AG future price: according to them, BAYN price has a max estimate of 32.83 CHF and a min estimate of 21.57 CHF. Watch BAYN chart and read a more detailed Bayer AG stock forecast: see what analysts think of Bayer AG and suggest that you do with its stocks.
BAYN reached its all-time high on Mar 18, 2015 with the price of 149.58 CHF, and its all-time low was 42.12 CHF and was reached on Sep 6, 2011. View more price dynamics on BAYN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
BAYN stock is 0.00% volatile and has beta coefficient of 0.80. Track Bayer AG stock price on the chart and check out the list of the most volatile stocks — is Bayer AG there?
Today Bayer AG has the market capitalization of 25.87 B, it has increased by 2.58% over the last week.
Yes, you can track Bayer AG financials in yearly and quarterly reports right on TradingView.
Bayer AG is going to release the next earnings report on Nov 11, 2025. Keep track of upcoming events with our Earnings Calendar.
BAYN earnings for the last quarter are 1.15 CHF per share, whereas the estimation was 0.84 CHF resulting in a 37.03% surprise. The estimated earnings for the next quarter are 0.36 CHF per share. See more details about Bayer AG earnings.
Bayer AG revenue for the last quarter amounts to 10.04 B CHF, despite the estimated figure of 10.07 B CHF. In the next quarter, revenue is expected to reach 9.13 B CHF.
BAYN net income for the last quarter is −185.99 M CHF, while the quarter before that showed 1.24 B CHF of net income which accounts for −114.95% change. Track more Bayer AG financial stats to get the full picture.
Yes, BAYN dividends are paid annually. The last dividend per share was 0.10 CHF. As of today, Dividend Yield (TTM)% is 0.39%. Tracking Bayer AG dividends might help you take more informed decisions.
As of Sep 8, 2025, the company has 92.81 K employees. See our rating of the largest employees — is Bayer AG on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Bayer AG EBITDA is 7.70 B CHF, and current EBITDA margin is 18.30%. See more stats in Bayer AG financial statements.
Like other stocks, BAYN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Bayer AG stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Bayer AG technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Bayer AG stock shows the sell signal. See more of Bayer AG technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.